secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0000950170-24-008937
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics shareholders reject proposal to issue up to 5M shares without pre-emptive rights
--------------------------------------------------------------------------------

- Proposal required 75% approval; received 3,139,498 For vs 2,724,101 Against and 26,719 Abstentions.
- Failure to grant authority limits board's ability to quickly raise capital by issuing new shares.
- Extraordinary general meeting held on January 30, 2024; vote is final.
- No broker non-votes as matter was considered routine under NYSE rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024008937/0000950170-24-008937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017024008937/itrm-20240130.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-008937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer